Intestinal microbiome changes and mechanisms of maintenance hemodialysis patients with constipationOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
The study characterized how the gut microbiome differs in maintenance hemodialysis patients with constipation. Constipation is common in these patients and affects quality of life, yet its associated gut flora had not been described. Researchers collected faecal samples and analyzed them with 16S ribosomal RNA gene sequencing. They compared species composition, alpha diversity, beta diversity, differential taxa, and predicted functional pathways across three participant groups.
Who was studied?
The study included 45 adults in China, split into three equal groups of 15. One group had maintenance hemodialysis with constipation, one had maintenance hemodialysis without constipation, and one was healthy controls. All faecal samples were profiled by 16S ribosomal RNA sequencing. This is the first report describing the intestinal microbiome features of hemodialysis patients who also have constipation.
What were the most important findings?
The constipation group had lower and less even bacterial diversity than the non-constipation and healthy groups. Its top genera included Enterococcus, Escherichia-Shigella, Bacteroides, Streptococcus, Bifidobacterium, Faecalibacterium and Akkermansia. Versus non-constipation patients, Enterococcus, Eggerthella, Allobaculum, Prevotella_7 and Gordonibacter were significantly higher (p less than 0.05). Kineothrix, Rhodopirellula and Weissella were significantly lower. Predicted functions enriched in constipation involved pyruvate metabolism and flavonoid biosynthesis.
What are the greatest implications of this study?
The results show that hemodialysis patients with constipation carry a distinct gut microbiome compared with those without constipation. Reduced diversity and specific genus shifts may relate to their bowel symptoms. These microbial signatures could become intestinal biomarkers or targets for therapies such as probiotics or faecal microbiota transplantation. Because the sample was small and observational, the findings show association rather than cause, and larger studies are needed to confirm them.